Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
This study has been completed.
Study NCT00752232   Information provided by Pfizer

First Received on September 11, 2008.   Last Updated on August 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alzheimer Disease
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies
Interventions listed in this trial
ACC-001
QS-21
PBS
Additional drug interventions recognized in this trial
QS 21
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services